BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 10 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding BioCardia, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 10 | 9 | −1 |
| Shares | 86.6K | 101.5K | +14.8K (+17.1%) |
| Value | $227.8K | $316.6K | +$88.8K (+39.0%) |
New holders (0)
Institutions that held BioCardia, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
None.
Sold out (1)
Institutions that held BioCardia, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Royal Bank of Canada | 26 | $0 |